2,693
+1.51%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medical Ikkou Group Co
Its shares trade on Tokyo Stock Exchange under the ticker 3353.T. It has been listed since 26 November 2004. In the fiscal year to 28 February 2026, it reported revenue of ¥54.98bn and net income of ¥1.28bn. At that date it held total assets of ¥37.52bn and shareholders' equity of ¥15.63bn.
Medical Ikkou Group Co., Ltd. engages in the management of dispensing pharmacies and residential nursing care facilities. The company is headquartered in Tsu-Shi, Mie-Ken. The company went IPO on 2004-11-26. is a Japan-based company mainly engaged in the operation of dispensing pharmacies that fill prescriptions for general patients based on the medical prescriptions issued by medical institutions. The firm operates in four business segments. The Dispensing Pharmacy segment is specialized in the sale of medical drugs based on medical prescriptions. The Healthcare segment is engaged in the operation of nursing care facilities, the leasing of medical facilities and others, as well as the medical care and nursing care related businesses. The Medicine Wholesale segment is engaged in the sale of pharmaceutical products to medical institutions and others. The Real Estate segment is engaged in the leasing of real estate properties.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 26 Nov 2004
- Employees
- 1,297
- Website
- m-ikkou.co.jp ↗
Leadership
Pay as last reported
- Mr. Toshihisa MinaminoPresident, Group Chief Executive Officer, President of Subsidiary, Representative Director, since 2005
- Mr. Kiyoshi HattoriPresident of Subsidiary, Director, since 2018
- Mr. Toshiharu SakuraiSenior Managing Director, President of Subsidiary, Representative Director, since 2006
- Mr. Kunihiko ToyamaManaging Director, Director of Finance & IR
- Mr. Takamitsu TachibanaSenior Executive Officer, General Affairs and Human Resources
- Mr. Yoshiyuki AdachiSenior Executive Officer, since 2006
- Mr. Kanichi EguchiSenior Executive Officer, President of Subsidiary, since 2023
- Mr. Katsumi KojimaSenior Executive Officer, since 2018
- Mr. Tsuyoshi ToyamaExecutive Officer, Director of Tokai Sales in Main Seibu Office Unit
- Mr. Masaru SakaiExecutive Officer, Director of General Affairs & Human Resources
- Mr. Kazuhisa FuruichiExecutive Officer
- Mr. Mitsuhiro ImamuraExecutive Officer, Director of General Affairs & Audit
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dispensing Pharmacy segment operates in Japan with 1,297 employees.
- Healthcare segment manages nursing care facilities and medical services.
- Medicine Wholesale segment supplies pharmaceuticals to medical institutions.
Weaknesses
- Real Estate segment leases properties but lacks diversification.
- Dispensing Pharmacy segment relies on prescription-based sales.
- Healthcare segment faces aging population challenges.
Opportunities
- Expanding Medicine Wholesale segment to new medical institutions.
- Growing demand for nursing care services in Japan.
- Increasing pharmacy sales through digital prescriptions.
Threats
- Regulatory changes in Japan's healthcare sector.
- Competition from larger pharmacy chains.
- Economic downturn affecting healthcare spending.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.